🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Malignant Primary Gliomas

Non-invasive Glioma Characterization Through Molecular Imaging NCT03684109NA1 site📍 Miami University of Miami · Tests: 3T MRI Scanner HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites📍 Birmingham📍 St Louis📍 Houston M.D. Anderson Cancer Center · Tests: G207 The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) NCT06118723n/a8 sites📍 San Francisco📍 Boston📍 Leuven Jasper Gerritsen · Tests: Supramaximal resection, Maximal safe resection FearLess in NeuroOncology NCT06989086NA1 site📍 Richmond Virginia Commonwealth University · Tests: Fearless in Neuro-Oncology Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors NCT06914479Phase 11 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Ad-hCMV-Flt3L, Ad-hCMV-TK, Biospecimen Collection, Magnetic Resonance Imaging, Survey Administration SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) NCT05254197n/a1 site📍 Seoul Seoul National University Hospital A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma NCT05622409n/a8 sites📍 Kaohsiung City📍 New Taipei City📍 Taichung National Health Research Institutes, Taiwan 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours NCT06630260Phase 1, Phase 23 sites📍 Cambridge📍 Sutton📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Avutometinib, Defactinib, Temozolomide ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors NCT04732065Phase 17 sites📍 San Francisco📍 Washington D.C.📍 Atlanta Sabine Mueller, MD, PhD · Tests: ONC206, Standard of Care Radiation Therapy, Optional Proton (1H) MR spectroscopy (MRS) 5G-PEARL: Paxalisib in Malignant Brain Tumours NCT07391215Phase 1, Phase 21 site📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Paxalisib, Temozolomide capsule Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors NCT05278208Phase 1, Phase 24 sites📍 Aurora📍 Cincinnati📍 Columbus Nationwide Children's Hospital · Tests: LUTATHERA® (Lutetium Lu 177 dotatate) The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma NCT04870944Phase 1, Phase 235 sites📍 Birmingham📍 Phoenix📍 Los Angeles Children's Oncology Group · Tests: Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy, Echocardiography Test, FACT Complex-targeting Curaxin…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy